Publication | Open Access
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
372
Citations
21
References
2017
Year
Diabetic RetinopathyOcular DiseaseRetinaOphthalmologyExperimental OphthalmologyDiabetesVisual AcuityVersus Panretinal PhotocoagulationMedicineClinical Efficacy
| Year | Citations | |
|---|---|---|
Page 1
Page 1